Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000899243-18-006955

Options or other derivatives

  • General Counsel and Secretary acquired 40,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
KASINGER JAMES R. General Counsel and Secretary 2018-03-07 Grant or award · Stock Option (Right to Buy) +40,000 40,000 D
Loading xslF345X03/doc4.xml…